Ignite Creation Date:
2024-05-06 @ 1:16 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01774786
Status:
COMPLETED
Last Update Posted:
2020-12-30
First Post:
2013-01-21
Brief Title:
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 HER2-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-10
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-21
First Submit QC Date:
January 21 2013
Study First Post Date:
2013-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-02-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-03
Last Update Post Date:
2020-12-30
Last Update Post Date Type:
ACTUAL